Ross Coppel

Title: Ross Coppel: Innovator in Malaria Research

Introduction

Ross Coppel is a distinguished inventor based in Armadale, Australia. He has made significant contributions to the field of malaria research, particularly through his innovative work on antigens related to Plasmodium falciparum. His research has implications for developing effective vaccines and treatments against malaria.

Latest Patents

Ross Coppel holds a patent for "The RESA and FIRA antigens of Plasmodium falciparum." This patent includes DNA molecules comprising polynucleotide sequences that correspond to the base sequence coding for antigens of Plasmodium falciparum, specifically the RESA and FIRA antigens. These DNA molecules can be expressed as polypeptides, which are crucial for stimulating immune responses against malaria. The patent highlights the potential for synthetic peptides or polypeptides that display the antigenicity of these antigens, paving the way for advancements in malaria immunology.

Career Highlights

Coppel is affiliated with the Walter and Eliza Hall Institute of Medical Research, where he has been instrumental in advancing research on malaria. His work has not only contributed to scientific knowledge but also has practical applications in public health. His dedication to understanding and combating malaria has positioned him as a key figure in this critical area of research.

Collaborations

Throughout his career, Ross Coppel has collaborated with notable scientists, including David J Kemp and Robin Fredric Anders. These collaborations have enhanced the depth and breadth of his research, leading to significant advancements in the understanding of malaria and its treatment.

Conclusion

Ross Coppel's innovative work in malaria research, particularly through his patent on Plasmodium falciparum antigens, showcases his commitment to improving global health. His contributions continue to inspire advancements in the fight against malaria.